Vernakalant
Vernakalant
Vernakalant (pronounced: ver-NAK-a-lant) is a medication used to treat atrial fibrillation and atrial flutter, two common types of abnormal heart rhythm. It is classified as an antiarrhythmic agent.
Etymology
The name "Vernakalant" is derived from the pharmaceutical company that developed it, Cardiome Pharma, and the word "ant", which is a common suffix for drugs that counteract a particular condition.
Usage
Vernakalant is used to restore normal heart rhythm in patients with atrial fibrillation or atrial flutter. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat.
Related Terms
- Atrial fibrillation: A heart condition that causes an irregular and often rapid heart rate.
- Atrial flutter: A condition similar to atrial fibrillation, where the heart's upper chambers (atria) beat too quickly.
- Antiarrhythmic agent: A group of pharmaceuticals that are used to suppress abnormal rhythms of the heart.
Side Effects
Like all medications, Vernakalant can cause side effects. Common side effects include dizziness, nausea, and shortness of breath. If these side effects persist or worsen, patients are advised to contact their healthcare provider.
Precautions
Vernakalant should not be used in patients with severe heart failure, a history of heart attack, or those with certain types of heart rhythm disorders. It should also be used with caution in patients with liver disease or kidney disease.
See Also
External links
- Medical encyclopedia article on Vernakalant
- Wikipedia's article - Vernakalant
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski